RITUXIMAB相关论文
目的:探讨利妥昔单抗联合环磷酰胺、阿霉素或表阿霉素、长春新碱、强的松(CHOP)化疗方案治疗B细胞非霍奇金淋巴瘤的临床效果。方法......
Backgrounds::GALLIUM is a global phase III study that demonstrated significant improvements in progression-free survival......
...
High efficacy of rituximab plus chemotherapy in treating human immunodeficiency virus-negative adult
Objective Burkitt lymphoma(BL)is a highly aggressive but potentially curable type of B-cell non-Hodgkin lymphoma(NHL)wit......
目的 Pneumocystis pneumonia is a potentially life-threatening infection that occurs in immunocompromised individuals.T-c......
Retuximab successfully treat unicentric Castleman disease complicated by paraneoplastic pemphigus an
Introduction Castleman disease(CD) was named after Dr Benjamin Castleman when he described 13 cases ofmediastinal lymphn......
The CD20-directed monoclonal antibody Rituximab (RTX) established a new era in the treatment of Non-Hodgkin Lymphoma (NH......
Observation of patients with recurrent non-Hodgkin lymphoma treated by rituximab in combination of C
Objective To explore and observe the clinicalal effect and side effect of patients with recurrent non-Hodgkin lymphoma (......
Cost effectiveness of different treatment strategies in the treatment of patients with moderate to s
Background: Policy makers increasingly emphasize their need for information based economic outcomes to make reimbursemen......
Spectrum of Epstein-Barr virus-associated diseases in allogeneic hematopoietic stem cell transplanta
Background: Epstein-Barr virus (EBV) infection may result in a spectrum of diseases in recipients of allogeneic hematopo......
Non-Hodgkin lymphoma (NHL) is one of the most common hematologic malignancies among adults for which the chimeric monocl......
Aberrtant expression of novel anti-inflammatory Interleukin-35 in patientswith type 1 diabetes:Assoc
Background: Type 1 diabetes is an autoimmune disease caused by the T cell.Tregs can generate a heterodimer formed by cov......
活体动物体内光学成像(optical in vivo imaging)采用生物发光(bioluminescence)与荧光(fluorescence)两种技术。通过这个系统，可以......
Prognostic significance of rituximab and radiotherapy for patients with primary mediastinal large B-
The aim of this study was to evaluate the prognostic importance of rituximab and radiotherapy in patients with primary m......
A retrospective analysis of real-world outcomes of elderly Chinese patients with diffuse large B-cel
...
...
Three-year Follow-up on the Safety and Effectiveness of Rituximab Plus Chemotherapy as First-Line Tr
...
Rituximab Treatment Strategy for Patients with Diffuse Large B-Cell Lymphoma after First-Line Therap
...
Fcγ receptor IIIA polymorphisms and efficacy of rituximab therapy on Chinese diffuse large B-cell ly
...
目的探讨利妥昔单抗联合强化疗治疗儿童侵袭性成熟B细胞淋巴瘤/白血病的安全性。方法收集2014年11月1日至2018年7月31日在上海交通......
利妥昔单抗是采用基因工程技术合成的人鼠嵌合单克隆抗体，通过特异性结合B细胞表面的跨膜蛋白CD20而发挥药理效应。利妥昔单抗临床......
儿童视神经脊髓炎谱系疾病(NMOSD)是一种主要累及视神经和脊髓的中枢神经系统的炎性脱髓鞘疾病谱。因其致残率及复发率较高，急性期......
Treatment outcome in children with central nervous system-positive Burkitt lymphoma using only intra
Background:With current chemotherapy treatment,>90%of survival has been obtained for Burkitt lymphoma(BL).In this study,......
目的:探讨n 99Tcn m-利妥昔单抗（n 99Tcn m-Rituximab）SPECT/CT对乳腺癌前哨淋巴结（SLN）的诊断效能。n 方法:......
Rituximab antibody conjugated Fe3O4 magnetic Nanoprobes and their labeling on malignant lymphoma Raj
Magnetic nanoparticles have been extensively studied for drug delivery, cancer therapy and diagnostic imaging [1].In......
Low symptomatic COVID-19 in an elderly patient with follicular lymphoma treated with rituximab-based
BACKGROUND Follicular lymphoma is an indolent lymphoma that may progress to a highly aggressive form requiring immunoche......
目的评价利妥昔单抗治疗成人原发性局灶性节段性肾小球硬化症（focal segmental glomerulosclerosis，FSGS）的疗效和安全性。方法回顾性......
小儿B细胞非霍奇金淋巴瘤多采用联合化疗序贯治疗 ,我们报告应用抗CD2 0 单克隆抗体%D%D利妥昔单抗 (美罗华 ,Rituximab)联合化疗 ......
...
目的探讨人粒细胞-巨噬细胞集落刺激因子(rhGM-CSF)联合R-CHOP方案治疗弥漫大B细胞淋巴瘤的临床疗效。方法选取2014年1月至2015年1......
目的比较恩替卡韦与拉米夫定预防合并既往乙肝感染[HBsAg(－)/HBcAb(＋)]的B细胞非霍奇金淋巴瘤(B-NHL)患者利妥昔单抗联合化疗HBV再激......
利妥昔单抗注射液作为最早应用于临床的CD20单抗类药物，广泛用于CD20阳性的淋巴瘤和一些自身免疫性疾病的治疗。近年的研究发现，该药......
目的：提高对利妥昔单抗导致的药物性肺损伤的认识。方法回顾性分析2例利妥昔单抗相关性药物性肺损伤患者的临床资料，并复习相关文献......
目的初步探讨脐带间充质干细胞(umbilical cord mesenchymal stem cells,UC-MSC)联合利妥昔单抗(rituximab,美罗华)与甲强龙对系统......
目的探讨利妥昔单抗在慢性淋巴细胞白血病(CLL)患者中的疗效。方法回顾性分析本院一线应用氟达拉滨+环磷酰胺±利妥昔单抗方案或环......
目的 总结淋巴结边缘区淋巴瘤(NMZL)的临床特点.方法 回顾性分析本院2002年1月至2013年9月淋巴瘤中心住院诊治的NMZL患者,总结临床......
【摘要】目的观察美罗华(利妥昔单抗,Rituximab)联合COTP方案化疗治疗方案治疗老年弥漫大B细胞性淋巴瘤的临床疗效和毒副反应。方......
A 44-year-old man was referred to our hospital with intermittent abdominal pain. Because distention of fluid- and gas-fi......
目的：探讨小剂量利妥昔单抗治疗继发于系统性红斑狼疮（SLE）的难治性血细胞减少症的临床疗效及安全性。方法选择2009年10月至2014年12......
1例63岁女性患者因非霍奇金淋巴瘤拟行R-CHOP(利妥昔单抗、环磷酰胺、阿霉素、长春新碱、泼尼松龙)方案治疗。首日给予利妥昔单抗6......
目的探讨小剂量利妥昔单抗治疗难治性特发性血小板减少性紫癜（ITP）序贯维持的临床疗效及安全性。方法33例难治性ITP患者接受小剂量利......
1例62岁男性B细胞非霍奇金淋巴瘤患者接受利妥昔单抗联合环磷酰胺、表柔比星、长春新碱、泼尼松方案治疗，治疗前胸部CT检查未见异常......
1例15岁男性弥漫性大B细胞淋巴瘤患儿接受由利妥昔单抗、环磷酰胺、表柔比星、长春新碱及泼尼松组成R-CHOP化疗方案治疗。在治疗第......
目的了解利妥昔单抗导致迟发性中性粒细胞减少(LON)的发生率和临床特点。方法利用医院信息系统收集2012年12月1日至2017年3月31日......
为探究吕家坨井田地质构造格局,根据钻孔勘探资料,采用分形理论和趋势面分析方法,研究了井田7......
